Milk Thistle (Silymarin): What the Evidence Actually Says About the Liver’s Best-Known Protector

Q: What is the right dose of milk thistle?

For liver support, 420 to 600 mg per day of a silymarin extract standardized to 70–80% silymarin, split into two or three doses taken with meals (fat improves absorption). A better-absorbed phytosome form (silybin bound to phospholipids) can be taken at a lower dose, around 100–200 mg of silybin once or twice daily. Look for a product that states its silymarin or silybin percentage.

Q: Who should avoid taking milk thistle?

Pregnant or breastfeeding women (there is not enough safety data), anyone allergic to ragweed, daisies, chrysanthemums, or marigolds, and anyone taking warfarin, certain statins, or other drugs metabolized by the same liver enzymes should avoid milk thistle unless a doctor clears it. People with hormone-sensitive conditions should get medical advice first, because of weak estrogen-like activity seen in lab studies.

For over 2,000 years, healers have reached for one plant whenever a liver was in trouble — and modern medicine, including a 2025 Cochrane review, has kept finding reasons to take it seriously. This is the evidence on milk thistle (silymarin): what it actually does, and what it can’t.

📋 Simple Summary

Milk thistle is a prickly plant whose seeds contain silymarin — the most-studied liver-protective compound in herbal medicine. People have used it for liver problems since ancient times, and a big chunk of modern science agrees: a 2025 Cochrane review (the gold standard for weighing medical evidence) found silymarin may improve liver health in people with fatty liver disease, and multiple meta-analyses of randomized trials show it lowers liver enzymes and improves insulin resistance. A special injectable form is even used in hospitals to help save people who eat deadly “death cap” mushrooms. But here’s the honest part: the evidence is for treating sick livers — not for making a healthy person’s liver “younger,” and not for extending life. For longevity specifically, the case is indirect: your liver is a master control organ, and protecting it matters — but nobody has shown milk thistle makes healthy people age slower.

The detailed breakdown continues below for those who want the full science.

Published: August 17, 2026
Evidence Tier: 🥇 Gold — for liver and metabolic-liver support, backed by a Cochrane review and multiple meta-analyses of randomized controlled trials. 🥉 Bronze — for direct anti-aging/lifespan, where the evidence is mechanistic only (no human longevity trials).
Category: 💊 Supplements & Compounds

⚖️ At a Glance: Pros & Cons

⚠️ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking milk thistle — especially if you take warfarin, statins, diabetes medication, or have a hormone-sensitive condition or an allergy to ragweed/daisies. The information below is for education only.

✅ Pros

Strongest benefit: Silymarin reduces liver enzymes and improves liver health in fatty liver disease (MASLD/NAFLD) — supported by a 2025 Cochrane review and several meta-analyses of randomized trials.
Blood-sugar support: Meta-analyses show silymarin modestly improves insulin resistance and glycemic control in type 2 diabetes.
Excellent safety record: One of the safest herbal supplements in existence — decades of use, trials lasting up to a year, with only mild digestive side effects.
Life-saving track record: Intravenous silybin is a hospital treatment that helps block deadly death-cap mushroom poisoning.

❌ Cons

No human longevity proof: Zero human evidence that milk thistle slows aging or extends life — the longevity case is indirect (liver health), not direct.
Poor absorption: Standard silymarin is poorly absorbed; only specialized “phytosome” forms (silybin bound to phospholipids) get around this.
Small, mixed trials: Many individual trials are small, short, and some are industry-funded — the meta-analyses show real but modest effects.
Who should avoid: People allergic to ragweed/daisies, and anyone on drugs metabolized by liver enzymes silymarin can affect (warfarin, some statins).

What Is Milk Thistle (Silymarin)?

Milk thistle (Silybum marianum) is a flowering plant in the daisy family (Asteraceae), native to the Mediterranean but now growing worldwide. It gets its name from the milky-white veins running through its leaves — which legend attributes to a drop of the Virgin Mary’s milk, hence “marianum.”

The part that matters is the seed, which contains a mixture of compounds called silymarin (about 1.5–3% of the seed’s weight). Silymarin is not a single molecule — it’s a family of flavonolignans (plant compounds built from a flavonoid plus a lignin unit):

Silybin (silibinin) — roughly 50–60% of silymarin and by far the most active and best-studied member. This is the compound in the hospital antidote and most research formulations.
Isosilybin, silydianin, and silychristin — the other family members, present in smaller amounts.

When a supplement label says “milk thistle extract, standardized to 80% silymarin,” it means 80% of the extract (by weight) is this flavonolignan family. Some premium products standardize specifically to silybin instead, which is a tighter specification.

The liver connection is ancient: the Greek physician Dioscorides and the Roman naturalist Pliny the Elder both described milk thistle as a remedy for liver and bile problems nearly 2,000 years ago. Modern research began in earnest in the 1960s–70s, when German scientists isolated silymarin and silybin and began studying them for liver disease.

How It Works

Milk thistle isn’t a single-key drug — it hits several systems at once, which is why it keeps showing up in studies on everything from fatty liver to blood sugar to mushroom poisoning. The four main mechanisms:

1. It’s a Powerful Antioxidant That Protects Cell Membranes

Your liver processes everything you swallow, breathe, and produce — and that constant work generates free radicals (unstable molecules that damage cells). Silymarin is a potent antioxidant that directly neutralizes free radicals and boosts your body’s own defenses by raising glutathione and superoxide dismutase — two of the liver’s built-in cleanup enzymes. Because silymarin also stabilizes the outer membrane of liver cells, it’s been described as a “membrane protectant” — it literally makes it harder for toxins to get into liver cells (PMID 39444787).

2. It Quiets Inflammation

Silybin dials down the inflammatory switch NF-κB and lowers inflammatory signals like TNF-α — the same low-grade, chronic inflammation (often called “inflammaging”) that drives much of age-related disease (PMID 41983124). This anti-inflammatory action is probably why silymarin helps in fatty liver disease, which is itself an inflammatory condition.

3. It Blocks Scarring and Helps the Liver Rebuild

Chronic liver damage leads to fibrosis — scar tissue that replaces working liver cells. Silymarin inhibits the cells that build scar tissue (hepatic stellate cells) and, critically, stimulates the liver to regenerate. A 2026 study found silibinin promotes liver-cell growth partly through mitophagy — the cell’s process of clearing out damaged mitochondria, its energy generators (PMID 42397441). This “clean up and rebuild” effect is central to its reputation as a liver healer.

4. It Fights Glycation and Improves Insulin Function

Glycation is when sugar molecules stick to proteins and damage them — one of the core processes of aging. Silymarin blocks glycation and the formation of AGEs (advanced glycation end-products) in lab studies (PMID 41511446), and meta-analyses of human trials show it improves insulin resistance — how well your cells respond to insulin (PMID 39855603). That’s why it has a real (if modest) evidence base in type 2 diabetes.

The Longevity Connection

Here’s what the evidence actually shows, outcome by outcome — and where the “anti-aging” label earns heavy caveats.

🫁 Fatty Liver & Metabolic Liver Disease — The Strongest Evidence (Gold)

This is milk thistle’s home turf. Metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly called NAFLD — is the buildup of fat in the liver linked to obesity and insulin resistance. It now affects roughly a third of adults worldwide, and there is still no approved drug for it. A 2025 Cochrane systematic review assessed silymarin for MASLD specifically (PMID 40552569), and a 2025 meta-analysis found silymarin significantly lowers the liver enzymes ALT, AST, and ALP across liver-injury studies (PMID 40221681). Another 2025 meta-analysis comparing interventions found silymarin improves NAFLD outcomes alongside lifestyle change (PMID 40738719). The effects are real but modest — silymarin is a useful adjunct, not a cure.

🍬 Blood Sugar & Insulin Resistance — Solid, Modest (Silver)

A 2025 systematic review and meta-analysis of randomized controlled trials found silymarin improves insulin resistance and insulin sensitivity in people taking it for at least 4 weeks (PMID 39855603). A 2025 network meta-analysis ranked silymarin among the most useful botanicals (alongside berberine and resveratrol) for cardio-metabolic risk factors in type 2 diabetes (PMID 40439602). A 2026 review maps the mechanism — silymarin appears to target both fat-tissue inflammation and the insulin-producing beta-cells of the pancreas (PMID 42483825).

🍄 Mushroom Poisoning — A Genuine Life-Saver

The single most dramatic evidence for silymarin’s liver protection isn’t a supplement study — it’s emergency medicine. Eating a death cap mushroom (Amanita phalloides) destroys the liver, with mortality above 50% without treatment. Intravenous silybin (sold in Europe as Legalon SIL) is part of the standard antidote regimen, because it blocks the mushroom toxin from being re-absorbed into liver cells. A 2026 analysis of poison-center data found oral silymarin also showed a signal for reducing mortality where IV silybin isn’t available (PMID 41378447), and 2026 data from the Czech Republic — one of the world’s biggest mushroom-picking nations — track how many antidote doses are needed (PMID 41973061). This is real, life-or-death evidence that silymarin protects the liver.

🧠 Brain, Kidney & More — Early and Preclinical

Silymarin and silybin show protective effects in preclinical models of Parkinson’s disease (PMID 42425390), diabetic kidney disease (PMID 41951014), and liver-related brain dysfunction called hepatic encephalopathy (PMID 42062034), and a 2025 meta-analysis found a kidney-protective signal across studies (PMID 40886393). Encouraging, but largely animal and cell work — not yet human proof.

⏳ Aging & Lifespan — Mechanistic Only (Bronze)

Silymarin’s mechanisms — antioxidant, anti-inflammatory, anti-glycation, mitochondrial cleanup — all touch core aging biology. But that’s a far cry from showing it slows human aging. There are no human trials showing milk thistle extends lifespan, healthspan, or biological age. If you’re buying it as a longevity drug, you’re buying the mechanism, not the evidence.

Key Studies

Study	Design	Key Finding
Wang et al. (2025) Cochrane Database Syst Rev	Cochrane systematic review	Assessed silymarin for MASLD (fatty liver disease); found it may offer liver benefit, while noting the evidence base is still developing.
Shahsavari et al. (2025) BMC Complement Med Ther	Meta-analysis of RCTs	Silymarin significantly reduced the liver enzymes AST, ALT, and ALP across liver-injury trials.
Yin et al. (2025) Diabetes Res Clin Pract	Meta-analysis of RCTs	Silymarin (≥4 weeks) improved insulin resistance and insulin sensitivity.
Zhang et al. (2025) Asia Pac J Clin Nutr	Meta-analysis	Compared silymarin, lifestyle change, and medications for NAFLD; silymarin improved liver outcomes alongside lifestyle intervention.
Miao et al. (2025) Phytother Res	Network meta-analysis	Ranked silymarin among the most useful botanicals for cardio-metabolic risk in type 2 diabetes (with berberine, resveratrol).
Frounchi et al. (2025) Biochemistry (Mosc)	Systematic review + meta-analysis	Found a kidney-protective (nephroprotective) signal for silymarin across studies.
Tangsuwanaruk et al. (2026) Clin Toxicol	Poison-center data	Oral silymarin showed a mortality-reduction signal in hepatotoxic mushroom poisoning where IV silybin is unavailable.
Méndez-Sánchez et al. (2019) BMC Pharmacol Toxicol	Bioavailability study	Silybin bound to phosphatidylcholine (“phytosome”) was absorbed far better than standard silymarin tablets.
Abenavoli et al. (2015) Expert Rev Gastroenterol Hepatol	RCT (n=30, overweight)	Mediterranean diet + silybin-vitamin E-phospholipid complex improved NAFLD markers in overweight patients.
Gheonea et al. (2025) Int J Mol Sci	Prospective clinical trial (n=200)	Silymarin + vitamin E + phospholipids improved liver steatosis, fibrosis, and metabolic parameters in MASLD patients.

Dosing and Safety

Recommended Forms

Form	What It Is	Notes
Standardized silymarin extract	Seeds standardized to 70–80% silymarin	The classic form; most studied; poorly absorbed so doses run higher.
Silybin-phospholipid (“phytosome”)	Silybin bound to phosphatidylcholine for better absorption	~4–10× better absorbed (PMID 30635055); allows lower, more effective doses.
Intravenous silybin (Legalon SIL)	Hospital-only injectable	For amatoxin mushroom poisoning — not a supplement, not for home use.

Dosing Protocol

Goal	Daily Dose	Notes
General liver support	420–600 mg silymarin (standardized)	Usually 140–200 mg three times daily with meals; fat improves absorption.
Phytosome form	~94.5–200 mg silybin	Lower dose because absorption is far better; 1–3 times daily.
Blood-sugar support	600 mg silymarin	The dose used in diabetes trials (200 mg three times daily).
Avoid	Unknown, unstandardized extracts	Buy products stating “% silymarin” (or silybin) and third-party tested; “milk thistle powder” without standardization is unpredictable.

Safety and Side Effects

Concern	Details
Digestive upset	The most common side effect — mild bloating, diarrhea, or nausea, usually dose-related and transient.
Laxative effect	Occasional loose stools, especially at higher doses.
Allergic reactions	Possible in people allergic to the daisy family (ragweed, chrysanthemums, marigolds, daisies).
Drug interactions	Silymarin affects liver enzymes (including CYP2C9) that break down drugs — can raise levels of warfarin, some statins, and other medications.
Blood-sugar lowering	Can add to the effect of diabetes drugs — watch for low blood sugar if combined.
Hormonal effects (theoretical)	Lab studies suggest weak estrogen-like activity; people with hormone-sensitive conditions should get medical advice first.

🥦 Food Sources & Equivalents

The honest answer up front: ❌ Supplement only — you cannot meaningfully get silymarin from food.

Can you get it from food?

No. Silymarin lives in the seeds of the milk thistle plant, and milk thistle seeds are not eaten as food. Brewing the seeds as a tea doesn’t help either, because silymarin dissolves very poorly in water — a cup of milk thistle tea delivers almost none of the active compound.

People sometimes confuse milk thistle with artichoke, a related thistle that is eaten as a vegetable. Artichoke contains its own liver-support compound (cynarin), which is why both appear in “liver detox” products — but cynarin is not silymarin, and the evidence for the two is not interchangeable.

How much food equals the research dose?

There’s no food math to do, because there’s no food source. The studied doses (420–600 mg of standardized silymarin per day) come from concentrated seed extract — roughly the amount in a large handful of raw seeds, which are bitter and not part of any diet.

The bottom line

❌ Supplement only. If you want silymarin’s liver-protective effects, you have to take the extract — food can’t get you there. (And if you’re after general liver health on a plate, the free wins are different: less alcohol, less sugar, and more fiber and coffee.)

❓ Common Questions About Milk Thistle (Silymarin)

What is milk thistle and how does it work?

Milk thistle is a plant whose seeds contain silymarin, a family of compounds (led by silybin) that has been used as a liver remedy for nearly 2,000 years. It works as an antioxidant that protects liver cells from damage, calms inflammation, blocks scar-tissue formation, and helps the liver rebuild itself. It also fights glycation — the sugar-driven damage to proteins that contributes to aging.

What does the evidence actually show?

The strongest evidence is for the liver: a 2025 Cochrane review and several meta-analyses of randomized trials show silymarin lowers liver enzymes and may improve fatty liver disease, and it also modestly improves insulin resistance and blood sugar in type 2 diabetes. A hospital-grade injectable form helps treat deadly mushroom poisoning. What it does not have is any human evidence that it slows aging or extends life — that part is mechanism only.

What’s the right dose?

For liver support, 420–600 mg per day of a silymarin extract standardized to 70–80% silymarin, split into two or three doses taken with meals (fat improves absorption). A better-absorbed “phytosome” form (silybin bound to phospholipids) can be taken at a lower dose, around 100–200 mg of silybin once or twice daily. Look for a product that states its silymarin or silybin percentage.

What are the risks and side effects?

Milk thistle is one of the safest herbal supplements available. The most common side effects are mild and digestive — bloating, nausea, or loose stools, usually at higher doses. The more important risks are interactions: it can affect liver enzymes that break down certain drugs (including warfarin and some statins) and can lower blood sugar when combined with diabetes medication.

Who should avoid it?

Pregnant or breastfeeding women (there’s not enough safety data), anyone allergic to ragweed, daisies, chrysanthemums, or marigolds, and anyone taking warfarin, certain statins, or other drugs metabolized by the same liver enzymes should avoid milk thistle unless a doctor clears it. People with hormone-sensitive conditions should get medical advice first, because of weak estrogen-like activity seen in lab studies.

The Bottom Line

Evidence Hierarchy

Milk thistle occupies an unusual spot in the supplement world: it has better human evidence than most botanicals — a Cochrane review, multiple meta-analyses of randomized trials, and a genuine emergency-medicine use — yet its evidence is aimed at a specific organ and specific diseases, not at aging itself.

The liver-protection story is real and unusually solid for a supplement. Silymarin lowers liver enzymes, may improve fatty liver disease (which affects roughly a third of adults), and improves insulin resistance — all backed by pooled analyses of randomized controlled trials. And the death-cap mushroom antidote is the kind of evidence most supplements will never have: silymarin’s active compound genuinely saves lives in a hospital setting.

What’s missing is the longevity leap. There are no human trials showing milk thistle slows biological aging, extends lifespan, or lengthens healthspan. Its anti-aging case rests entirely on mechanism — antioxidant, anti-inflammatory, anti-glycation, mitochondrial cleanup — which is promising and coherent, but not proof.

Our Verdict

For liver and metabolic health, milk thistle is one of the better-evidenced supplements you can buy — a reasonable, low-risk adjunct for someone with fatty liver, elevated liver enzymes, or insulin resistance (with a doctor’s sign-off, especially if you’re on other medications).

For longevity, the honest label is “plausible but unproven.” Your liver is a master control organ, and protecting it is genuinely important as you age — but there are free interventions with far stronger longevity evidence: cut alcohol, cut added sugar, lose excess weight, and drink coffee (which has its own strong liver-protection data). Milk thistle is a support act, not the headline.

If you decide to take it: choose a silymarin extract standardized to 70–80% (or a silybin-phospholipid “phytosome” for better absorption), dose 420–600 mg/day (or ~100–200 mg silybin for the phytosome form) with meals, and confirm the product is third-party tested. Skip unstandardized “milk thistle powder.”

Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Milk thistle (silymarin) can interact with warfarin, statins, diabetes medications, and other drugs, and is not appropriate for everyone. Always consult your healthcare provider before starting any new supplement — especially if you are pregnant, nursing, have a hormone-sensitive condition, have a ragweed/daisy allergy, or take prescription medication.

Sources

Wang C, Shang Y, Kanaan G, et al. Silymarin for adults with metabolic dysfunction-associated steatotic liver disease. Cochrane Database Syst Rev. 2025. PMID: 40552569
Shahsavari K, Ardekani SS, Ardekani MRS, et al. Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury. BMC Complement Med Ther. 2025. PMID: 40221681
Yin S, Zhu F, Liu Y, et al. Effects of silymarin on insulin resistance and sensitivity: a systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2025. PMID: 39855603
Zhang Z, Li S, Sun J, et al. Efficacy of different interventions for nonalcoholic fatty liver disease: a meta-analysis of lifestyle modifications, silymarin, and medications. Asia Pac J Clin Nutr. 2025. PMID: 40738719
Miao R, Zhang B, Zhou D, et al. Clinical efficacy of curcumin, resveratrol, silymarin, and berberine on cardio-metabolic risk factors among patients with type 2 diabetes mellitus: a systematic review and network meta-analysis. Phytother Res. 2025. PMID: 40439602
Frounchi N, Mahmoodpoor F, Zakavi SS, et al. Nephroprotective effects of silymarin: a systematic review and meta-analysis. Biochemistry (Mosc). 2025. PMID: 40886393
Tangsuwanaruk T, Tansuwannarat P, Tongpoo A, et al. Effect of oral silymarin in patients with acute hepatotoxic mushroom poisoning: an analysis of poison center data. Clin Toxicol (Phila). 2026. PMID: 41378447
Pelclová D, Navrátil T, Kieslichová E, et al. Trends in Amanita phalloides intoxications in the Czech Republic: how many antidotes are needed? Cent Eur J Public Health. 2026. PMID: 41973061
Méndez-Sánchez N, Dibildox-Martinez M, Sosa-Noguera J, et al. Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers. BMC Pharmacol Toxicol. 2019. PMID: 30635055
Abenavoli L, Greco M, Nazionale I, et al. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25617046
Federico A, Conti V, Russomanno G, et al. A long-term treatment with silybin in patients with non-alcoholic steatohepatitis stimulates catalase activity in human endothelial cells. In Vivo. 2017. PMID: 28652427
Gheonea DI, Tocia C, Sacerdoțianu VM, et al. Therapeutic efficacy of silymarin, vitamin E, and essential phospholipid combination therapy on hepatic steatosis, fibrosis, and metabolic parameters in MASLD patients. Int J Mol Sci. 2025. PMID: 40564891
Sukeepaisarnjaroen W, Chaiteerakij R, Gonzalez EV, et al. Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study. Drugs Context. 2026. PMID: 41993723
Selc M, Macova R, Babelova A, et al. Novel strategies enhancing bioavailability and therapeutical potential of silibinin for treatment of liver disorders. Drug Des Devel Ther. 2024. PMID: 39444787
Kebir NE, Berber N, Mehdi Y, et al. Silymarin in type 2 diabetes — targeting adipose tissue dysfunction and pancreatic β-cell damage: a review. Biomol Biomed. 2026. PMID: 42483825
Wang Y, Yang Y. Advances in research on the mechanisms of anti-inflammation of silybin: a review. Front Immunol. 2026. PMID: 41983124
Xu F, Albadry M, Dirsch O, et al. Silibinin promotes hepatocyte proliferation through PINK1/Parkin-mediated mitophagy to alleviate acetaminophen-induced liver injury. Clin Exp Med. 2026. PMID: 42397441
Yang YJ, Yu YP, Lin KH, et al. Superior antiglycation efficacy of silymarin from Silybum marianum in human αA-crystallin: implications for diabetic cataract prevention. Biosci Biotechnol Biochem. 2026. PMID: 41511446
Tanoy NM, Chowdhury MN, Tasnim Z, et al. Silibinin as a modulator of redox-onco axis: a natural inhibitor of oxidative damage and tumor progression. Pathol Res Pract. 2026. PMID: 42054809
Mohammadi D, Aghayan AH, Mohammadi D, et al. Therapeutic effects of silibinin in preclinical animal models of gastrointestinal cancers: a systematic review and meta-analysis. BMC Cancer. 2026. PMID: 42437897